Science and Society
Molecular life sciences research makes major contributions to societal goals such as understanding and controlling human diseases, developing new medicines, materials and foods, as well controlling diseases of plants and animals. The public, policy makers and the media take interest in many issues related to the aims, outcomes and implications of such research, which often has an ethical dimension. Among the publicly debated issues are stem cell research, personalized medicine, genetically modified organisms, food safety, and animal health and welfare.
The FEBS Science and Society Committee works at the interface between scientists, policy makers and the wider public. The Committee contributes through creating strategies and mechanisms for the shaping of policy and as a key European Federation focusing the efforts of member organizations on catalysing initiatives.
Scientific policy at the European level can be split into two strands: funding and regulation. Within the area of science funding the Committee aims to empower scientists to take a more active role in strategic plans and to enable them to speak with a unified voice. By consulting the scientific community it is much easier to generate a bottom-up approach and, most importantly, to create a vision for life sciences, which can be supported through European and national government money. The other aspect to science policy is working on the regulatory side, ensuring that there is sound scientific input into new laws and regulations that impact the life sciences. Within this, the Committee aims to champion diversity within biochemical sciences.
Working with the wider public beyond policy makers, the Committee, in collaboration with the FEBS Constituent Societies, aims to increase the understanding of biochemical science across Europe. This is particularly important as life sciences have undergone a tremendous explosion during recent years. This rapid development has resulted in a number of ethical issues and the Committee aims to provide unbiased contributions to the wider societal debate about the use of these technologies, linking to the Committee’s work on regulatory policy. As part of this objective the Committee organizes a science and society symposium at the annual FEBS Congress.
Upcoming activities
Support for 'Science and Society' Constituent Society events on the Microbiome
Following a call to FEBS Constituent Societies for proposals for events/activities to take the 2018 FEBS Science and Society Congress topic 'Healthy Microbiome, Healthy Host?' to a wider audience, the following events are being supported by FEBS in 2019:
• The Biological Society of Cyprus: a workshop on the microbiome
16 February 2019; University of Nicosia, Cyprus
Organized by the Biological Society of Cyprus and University of Nicosia Medical School. For more information, see the FEBS Network post here
• The Italian Society of Biochemistry and Molecular Biology (SIB): a one-day conference on the microbiome
31 May 2019; Università Politecnica delle Marche, Ancona, Italy
Organized by the Department of Clinical Sciences, Section of Biochemistry, Biology and Physics of Università Politecnica delle Marche
• The Spanish Society for Biochemistry and Molecular Biology (SEBBM): a school-student and public outreach event on allergy and the microbiome
San Pablo CEU University, Madrid, Spain
Organized by SEBBM, San Pablo CEU University and the Thematic Research Network ARADYAL of the Instituto de Salud Carlos III
The next call from the FEBS Science and Society Committee for FEBS Constituent Society proposals for event/activity funding will be in relation to the 2019 FEBS Congress Science and Society topic below.
FEBS Special Session on Science and Society at the 44th FEBS Congress – Personalised medicine: a future vision
Tuesday July 9; 16:15–18:15 at the 44th FEBS Congress, Krakow, Poland; 6–11 July 2019
The advance in the knowledge of the human genome and in the technology that allows it to be sequenced, analyzed and compared, is allowing the beginning of a new era in the study of human diseases. Likewise, it opens new opportunities to develop tailor-made treatments, especially to understand and treat rare diseases, as well as new ethical challenges in the use of biomedical information.
Chairs: Emmanouil Fragkoulis, Greece; Isabel Varela-Nieto, Spain
• An introduction to personalised medicine, Stylianos E. Antonarakis, Switzerland
• Bioethics and personalised medicine, Andrzej Kochanski, Poland
• Precision medicine of rare diseases and the link with common disorders, Francesc Palau, Spain
• Discussion
Recent activities
Science and Society events
Activities of the FEBS Science and Society Committee from late 2017 through 2018 are summarized in the November 2018 issue of FEBS News, pages 14–15.
FEBS-supported Science and Society Sessions/Activities for FEBS Constituent Societies on the theme of CRISPR were organized by the Spanish Society for Biochemistry and Molecular Biology, Life Sciences Switzerland, and the Biochemical Society (UK).
The FEBS Congress 2018 Special Science and Society Session in Prague on 'Healthy microbiome, healthy host?' featured talks from Mike Curtis, Domingo Barber and Koen Venema. For more details, see the session outline on the 2018 FEBS Congress website here.
Research Integrity: A Code of Conduct
As a charitable organization, FEBS aims to advance research and education in the molecular life sciences through its journals, fellowships, courses, congress and other activities. Ethical conduct is demanded in all activities supported by FEBS. Given recent increased concerns among scientists and the public about good research practice, and following discussion of codes of conduct by the FEBS Science and Society Committee, FEBS has decided to subscribe to the 'European Code of Conduct for Research Integrity'. This document was prepared by the European Science Foundation/All European Academies, and FEBS is grateful to the European Science Foundation for permission to refer to it. The Code calls for researchers, public and private research organizations, universities and funding organizations to observe and promote the principles of integrity in scientific and scholarly research, including reliability in performing research, honesty in communication, objectivity, impartiality and independence, openness and accessibility, duty of care, fairness in providing references and giving credit, and responsibility for the scientists and researchers of the future.
Other work
Contacts with EU political officers, EMBO, ISE and other organizations have taken place in order to exchange information and coordinate activities related to science and society. In particular, under the umbrella of the BioMed Alliance, FEBS has participated in efforts to obtain from the EU the best research budget for the next Framework program (FP9), and also for inclusion of key points of interest to members of FEBS Constituent Societies such as: an increased ERC program budget, small network projects that may give rise to large projects, international labs for neighbouring countries, creation of common resource platforms such as biobanks, reinforcement of the Marie Curie program, funding for shorter stay European PhD programs, reorganization of evaluation processes, and minimization of bureaucracy.
The work of the FEBS Science and Society Committee is reported to FEBS Council and in the Science and Society Committee appendix of the FEBS Annual Report. Occasional reports also appear in FEBS News. For members of the Science and Society Committee, click here. The full terms of reference of the Committee are given in the FEBS Bylaws.
A short history
The FEBS Council approved the establishment of a Science and Society Committee, chaired by Federico Mayor, Spain, at its 27th Meeting, held in Lisbon in 2001. Alongside its other work, the Committee has organized a science and society programme at each of the FEBS annual Congresses since 2002, as summarized below.
*The past role of FEBS, together with other research organizations in Europe, in working towards the creation of the European Research Council (ERC) for investigator-driven funding within Europe is described in a recent article in Molecular Oncology:
Celis, J.E. and Gago, J.M. (2014) Shaping science policy in Europe. Mol. Oncol. 8, 447–457
Science and Society programmes at past FEBS Congresses:
2018 (Prague), Session on Healthy microbiome, healthy host?
2017 (Jerusalem), Session on The role of CRISPR in Personalized Medicine: Legal and Ethical Problems
2016 (Kuşadası – cancelled), Session was planned on GMOs: Applications to Medicine and Agronomy (two speakers shared slide sets on the Congress website in absence of live event)
2015 (Berlin), Session on Evolutionary Medicine, subtitled 'Why do we get sick?'
2014 (Paris; FEBS–EMBO Conference), Session on Safety and Security in the Biological Sciences, and Roundtable on New Trends in European Scientific Policy
2013 (St Petersburg), Workshop on Personalized Cancer Medicine
2012 (Sevilla; IUBMB–FEBS Congress), Session on AIDS, and joint workshops with FEBS, IUBMB and SEBBM Education Committees on biochemistry and molecular biology education
2011 (Torino), Session on Genetic Diseases
2010 (Gothenburg), Session on Biofuels are more than Fuels
2009 (Prague), Session on Ethics and Legislation in Stem Cell Research
2008 (Athens), Session on Biochemistry-Quality of Life-New Challenges
2007 (Vienna), (i) A town hall meeting on Re-Emerging Diseases - A Global Threat; (ii) Inclusion of Science & Society issues in a workshop on Lipids and Aging; and (iii) a Science and Society Session on Alzheimer Disease -"Aging of the Brain"
2006 (Istanbul), Session on Genetically Modified Plants: Current Status and Future Challenges
2005 (Budapest); Special Lecture on Science, Society and Public Understanding of Science
2004 (Warsaw), Session on Biological, Medical and Ethical Aspects of Stem Cell Research
2003 (Special Meeting, Brussels), Three Panel Sessions on (i) Science and Society in Europe; (ii) Stem Cell Research and Society; and (iii) Genetically Modified Organisms: Public Perception, Regulation and Role of Media
2002 (Istanbul), Panel Session on Science, Society and the Media